Licheng Wu Selected Research

Licheng Wu Research Topics

Disease

6	Neoplasms (Cancer) 10/2021 - 06/2014
5	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 06/2014
3	Sepsis (Septicemia) 03/2006 - 11/2003
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2016
2	Colitis 04/2024 - 11/2019
2	Inflammation (Inflammations) 11/2019 - 05/2011
2	Critical Illness (Critically Ill) 06/2006 - 03/2005
1	Infertility (Sterility) 03/2024
1	Hepatocellular Carcinoma (Hepatoma) 01/2024
1	Dyslipidemias (Dyslipidemia) 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024
1	Hypercholesterolemia 01/2024
1	Respiratory Sounds (Crackle) 01/2023
1	Anemia 01/2023
1	Cough 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Colonic Neoplasms (Colon Cancer) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021
1	Crohn Disease (Crohn's Disease) 11/2019
1	Ulcerative Colitis 11/2019
1	Insulin Resistance 01/2016
1	Hyperglycemia 01/2016
1	Carcinogenesis 06/2014
1	Pediatric Obesity 01/2014
1	Thrombosis (Thrombus) 03/2009
1	Hypoxia (Hypoxemia) 01/2007
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2007
3	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 11/2014
2	OccludinIBA 11/2019 - 05/2011
2	CytokinesIBA 11/2019 - 02/2003
2	Messenger RNA (mRNA)IBA 03/2016 - 06/2014
2	bicalutamide (Casodex)FDA LinkGeneric 03/2016 - 11/2014
1	semaglutideIBA 04/2024
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2024
1	ResveratrolIBA 04/2024
1	CholesterolIBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	AlbuminsIBA 01/2023
1	Ambroxol (Mucosolvan)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2023
1	Caspase 3 (Caspase-3)IBA 11/2019
1	Small Interfering RNA (siRNA)IBA 03/2016
1	enzalutamideIBA 03/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	KATP ChannelsIBA 01/2016
1	Diazoxide (Hyperstat)FDA Link 01/2016
1	Connexin 43 (Connexin43)IBA 01/2015
1	AndrogensIBA 11/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2014
1	Phosphotransferases (Kinase)IBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 06/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 06/2014
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2014
1	ClaudinsIBA 05/2011
1	Tight Junction ProteinsIBA 05/2011
1	Peptide Hydrolases (Proteases)FDA Link 03/2009
1	Inosine FDA Link 01/2007
1	LectinsIBA 01/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2006
1	AcidsIBA 03/2006
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2004
1	Virulence Factors (Pathogenicity Factors)IBA 11/2003

Therapy/Procedure

7	Therapeutics 01/2024 - 03/2005
3	Castration 03/2016 - 06/2014
1	Oral Administration 04/2024
1	Transplantation 03/2024
1	Immunotherapy 01/2024
1	Length of Stay 01/2023
1	Thoracotomy 08/2021
1	Glycemic Control 01/2016
1	Thrombolytic Therapy 03/2009